B., C., P., S., K., C., J., S., C., P., S., S., . . . A., P. (2014). Weekly versus three-weekly cisplatin as an adjunct to radiation therapy in high-risk stage I-IIA cervical cancer after surgery: A randomized comparison of treatment compliance.

B., Chumworathayi, et al. Weekly Versus Three-weekly Cisplatin As an Adjunct to Radiation Therapy in High-risk Stage I-IIA Cervical Cancer After Surgery: A Randomized Comparison of Treatment Compliance. 2014.

B., Chumworathayi, et al. Weekly Versus Three-weekly Cisplatin As an Adjunct to Radiation Therapy in High-risk Stage I-IIA Cervical Cancer After Surgery: A Randomized Comparison of Treatment Compliance. 2014.